Skip to main content

ASCPT 2023 Annual Meeting Main banner

Tweets by ASCPT 2023 Annual Meeting

Drug Utilization & Outcomes (DUO)

Drug Utilization & Outcomes (DUO)

Type here to filter the list

PT-005 - MAJOR POTENTIAL DRUG-DRUG INTERACTIONS AMONG MEDICAID-INSURED CHILDREN IN THE OUTPATIENT SETTING.

Favorite
PT-010 - PREDICTING LINEZOLID-INDUCED HEMATOLOGIC TOXICITIES IN REAL-WORLD PATIENTS WITH HYBRID MODELING.

Favorite
PT-013 - CONCURRENT GABAPENTIN AND OPIOID USE AND RISK OF MORTALITY IN MEDICARE RECIPIENTS WITH NON-CANCER PAIN.

Favorite
PT-017 - CARDIOVASCULAR SAFETY OF CARFILZOMIB IN KOREA: RETROSPECTIVE COHORT STUDY USING A NATIONWIDE ADMINISTRATIVE CLAIM DATABASE.

Favorite
PI-001 - ASSOCIATION BETWEEN BLEEDING RISK AND INITIAL P2Y12 INHIBITOR SELECTION AND DE-ESCALATION AMONG PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) AND PERCUTANEOUS CORONARY INTERVENTION (PCI).

Favorite
PI-002 - FENO AND SMOKING HISTORY, NOT EOSINOPHILIA, MAY PREDICT THE EFFICACY OF TIOTROPIUM (SPIRIVA RESPIMAT) IN UNCONTROLLED ASTHMA PATIENTS DESPITE ICS/LABA TREATMENT: A PILOT STUDY.

Favorite
PI-003 - PDE5 INHIBITORS AND DEMENTIA RISK: A REAL-WORLD STUDY.

Favorite
PI-004 - SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF A NOVEL MACROCYCLIC GADOLINIUM-BASED CONTRAST AGENT, HNP-2006, AFTER A SINGLE INTRAVENOUS ADMINISTRATION IN HEALTHY SUBJECTS.

Favorite
PI-005 - USING REAL WORLD EVIDENCE (RWE) TO ASSESS DRUG-DRUG INTERACTION (DDI) BETWEEN PAXLOVID AND THE TOP 100 PRESCRIBED DRUGS IN THE US.

Favorite
RWE-001 - USING REAL WORLD EVIDENCE (RWE) TO ASSESS DRUG-DRUG INTERACTION (DDI) BETWEEN PAXLOVID AND THE TOP 100 PRESCRIBED DRUGS IN THE US.

Favorite
RWE-002 - CONCURRENT GABAPENTIN AND OPIOID USE AND RISK OF MORTALITY IN MEDICARE RECIPIENTS WITH NON-CANCER PAIN.

Favorite
RWE-005 - ASSOCIATION BETWEEN BLEEDING RISK AND INITIAL P2Y12 INHIBITOR SELECTION AND DE-ESCALATION AMONG PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) AND PERCUTANEOUS CORONARY INTERVENTION (PCI).

Favorite
RWE-007 - PREDICTING LINEZOLID-INDUCED HEMATOLOGIC TOXICITIES IN REAL-WORLD PATIENTS WITH HYBRID MODELING.

Favorite
RWE-008 - PDE5 INHIBITORS AND DEMENTIA RISK: A REAL-WORLD STUDY.

Favorite